These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4707416)

  • 1. Reversible hearing loss due to ethacrynic acid in occult renal failure. Case report.
    Carmody JP; Sauer EP; Gladney J
    Mo Med; 1973 May; 70(5):307-9. PubMed ID: 4707416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hearing disorder in chronic renal insufficiency].
    Pluzhnikov MS; Kozhevnikova AP; Bondarenko BB
    Vestn Otorinolaringol; 1977; (1):95-9. PubMed ID: 322379
    [No Abstract]   [Full Text] [Related]  

  • 3. Case report. Diuretic induced ototoxicity in preeclampsia.
    Morrison JC; Fort AT; Fish SA
    J Tenn Med Assoc; 1971 Jan; 64(1):36-7. PubMed ID: 5539343
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hearing disorders after treatment with ethacrynic acid (Edecrin) in patients with reduced kidney function].
    Stenbaek O
    Tidsskr Nor Laegeforen; 1970 Jan; 90(1):34. PubMed ID: 5426184
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ototoxicity of ethacrynic acid in patients with reduced kidney function].
    Ugeskr Laeger; 1970 Apr; 132(17):800. PubMed ID: 5447313
    [No Abstract]   [Full Text] [Related]  

  • 6. [Review of observed gentamicin ototoxicity cases in Germany].
    Federspil P
    HNO; 1971 Nov; 19(11):328-31. PubMed ID: 5138270
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of ethacrynic acid on the movement of phosphorus in the kidneys].
    Plouvier B; Haftel Y; François M; Hatron PY; Lemaire P; Devulder B
    Lille Med; 1978 May; 23(3):184-6. PubMed ID: 651549
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ethacrynic acid and hearing disorders].
    Policlinico Prat; 1971 Dec; 78(24):1006-8. PubMed ID: 5157011
    [No Abstract]   [Full Text] [Related]  

  • 9. Ototoxic drugs and poor renal function.
    Matz GJ; Naunton RF
    JAMA; 1968 Nov; 206(9):2119. PubMed ID: 5754935
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diuretics].
    Gessler U
    Fortschr Med; 1978 Jun; 96(23):1221-2. PubMed ID: 658875
    [No Abstract]   [Full Text] [Related]  

  • 11. Diuretics in chronic renal insufficiency.
    Guédon J; Legrain M
    Adv Nephrol Necker Hosp; 1972; 2():231-5. PubMed ID: 4219688
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethacrynic acid in acute tubular necrosis. Indications and effect on the natural course.
    Kjellstrand CM
    Nephron; 1972; 9(6):337-48. PubMed ID: 4655134
    [No Abstract]   [Full Text] [Related]  

  • 13. [The diuretic activity of ethacrynic acid].
    Hwang YS
    Taiwan Yi Xue Hui Za Zhi; 1969 Jul; 68(7):372-80. PubMed ID: 5259196
    [No Abstract]   [Full Text] [Related]  

  • 14. Dropsical bullae in patients with diabetes mellitus and chronic renal failure receiving high-dose frusemide.
    Tamimi NA; al-Heresh AM; Rowland-Payne CM
    Nephrol Dial Transplant; 1995 Oct; 10(10):1943. PubMed ID: 8592614
    [No Abstract]   [Full Text] [Related]  

  • 15. [Improvement of acidosis treatment in chronic kidney failure using ethacrynic acid].
    Quellhorst E; Henning HV; Mietzsch G; Stegemann I; Scheler F
    Verh Dtsch Ges Inn Med; 1968; 74():591-5. PubMed ID: 5714390
    [No Abstract]   [Full Text] [Related]  

  • 16. Iatrogenic hypokalemia of pregnancy by furosemide and ethacrynic acid.
    Fort AT; Morrison JC; Fish SA
    J Reprod Med; 1971 May; 6(5):207-8. PubMed ID: 5094731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of ethacrynic acid for acute renal failure].
    Lemieux G; Talbot P; Laurent G
    Union Med Can; 1971 Aug; 100(8):1539-44. PubMed ID: 5314865
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials in progression of chronic renal failure.
    Striker GE; Klahr S
    Adv Intern Med; 1997; 42():555-95. PubMed ID: 9048130
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ethacrynic acid: research on the mechanism of action and clinical use].
    Zucchelli P; Petrella A; Fusaroli M; Sasdelli M; Melica A
    Minerva Med; 1968 Jan; 59(5):129-45. PubMed ID: 5639119
    [No Abstract]   [Full Text] [Related]  

  • 20. [Update nephrology-I. Etiology and possibilities for modifying the progression of chronic renal failure].
    Stein G; Sperschneider H; Fünfstück R; Haufe C
    Med Klin (Munich); 1996 Feb; 91(2):76-81. PubMed ID: 8850102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.